142 related articles for article (PubMed ID: 30594809)
1. Decreased circulating ErbB4 ectodomain fragments as a read-out of impaired signaling function in amyotrophic lateral sclerosis.
Lopez-Font I; Sogorb-Esteve A; Javier-Torrent M; Brinkmalm G; Herrando-Grabulosa M; García-Lareu B; Turon-Sans J; Rojas-García R; Lleó A; Saura CA; Zetterberg H; Blennow K; Bosch A; Navarro X; Sáez-Valero J
Neurobiol Dis; 2019 Apr; 124():428-438. PubMed ID: 30594809
[TBL] [Abstract][Full Text] [Related]
2. ErbB4 Mutation that Decreased NRG1-ErbB4 Signaling Involved in the Pathogenesis of Amyotrophic Lateral Sclerosis/Frontotemporal Dementia.
Sun L; Cheng B; Zhou Y; Fan Y; Li W; Qiu Q; Fang Y; Xiao S; Zheng H; Li X
J Alzheimers Dis; 2020; 74(2):535-544. PubMed ID: 32065797
[TBL] [Abstract][Full Text] [Related]
3. Altered immunoreactivity of ErbB4, a causative gene product for ALS19, in the spinal cord of patients with sporadic ALS.
Takahashi Y; Uchino A; Shioya A; Sano T; Matsumoto C; Numata-Uematsu Y; Nagano S; Araki T; Murayama S; Saito Y
Neuropathology; 2019 Aug; 39(4):268-278. PubMed ID: 31124187
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Role of Neuregulin 1 Type III in SOD1-Linked Amyotrophic Lateral Sclerosis.
Mòdol-Caballero G; García-Lareu B; Verdés S; Ariza L; Sánchez-Brualla I; Brocard F; Bosch A; Navarro X; Herrando-Grabulosa M
Neurotherapeutics; 2020 Jul; 17(3):1048-1060. PubMed ID: 31965551
[TBL] [Abstract][Full Text] [Related]
5. Parvalbumin interneurons dysfunction is potentially associated with FαMNs decrease and NRG1-ErbB4 signaling inhibition in spinal cord in amyotrophic lateral sclerosis.
Kang Q; Jiang S; Min J; Hu F; Xu R
Aging (Albany NY); 2023 Dec; 15(24):15324-15339. PubMed ID: 38157256
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of novel ERBB4 variant associated with sporadic amyotrophic lateral sclerosis (ALS).
Kwon Y; Kang M; Jeon YM; Lee S; Lee HW; Park JS; Kim HJ
J Neurol Sci; 2024 Feb; 457():122885. PubMed ID: 38278691
[TBL] [Abstract][Full Text] [Related]
7. ERBB4 mutations that disrupt the neuregulin-ErbB4 pathway cause amyotrophic lateral sclerosis type 19.
Takahashi Y; Fukuda Y; Yoshimura J; Toyoda A; Kurppa K; Moritoyo H; Belzil VV; Dion PA; Higasa K; Doi K; Ishiura H; Mitsui J; Date H; Ahsan B; Matsukawa T; Ichikawa Y; Moritoyo T; Ikoma M; Hashimoto T; Kimura F; Murayama S; Onodera O; Nishizawa M; Yoshida M; Atsuta N; Sobue G; ; Fifita JA; Williams KL; Blair IP; Nicholson GA; Gonzalez-Perez P; Brown RH; Nomoto M; Elenius K; Rouleau GA; Fujiyama A; Morishita S; Goto J; Tsuji S
Am J Hum Genet; 2013 Nov; 93(5):900-5. PubMed ID: 24119685
[TBL] [Abstract][Full Text] [Related]
8. Neuregulin-1 and ALS19 (ERBB4): at the crossroads of amyotrophic lateral sclerosis and cancer.
Adashek JJ; Pandya C; Maragakis NJ; De P; Cohen PR; Kato S; Kurzrock R
BMC Med; 2024 Feb; 22(1):74. PubMed ID: 38369520
[TBL] [Abstract][Full Text] [Related]
9. Neuregulin-1 promotes functional improvement by enhancing collateral sprouting in SOD1(G93A) ALS mice and after partial muscle denervation.
Mancuso R; Martínez-Muriana A; Leiva T; Gregorio D; Ariza L; Morell M; Esteban-Pérez J; García-Redondo A; Calvo AC; Atencia-Cibreiro G; Corfas G; Osta R; Bosch A; Navarro X
Neurobiol Dis; 2016 Nov; 95():168-78. PubMed ID: 27461051
[TBL] [Abstract][Full Text] [Related]
10. Neuregulin 1 confers neuroprotection in SOD1-linked amyotrophic lateral sclerosis mice via restoration of C-boutons of spinal motor neurons.
Lasiene J; Komine O; Fujimori-Tonou N; Powers B; Endo F; Watanabe S; Shijie J; Ravits J; Horner P; Misawa H; Yamanaka K
Acta Neuropathol Commun; 2016 Feb; 4():15. PubMed ID: 26891847
[TBL] [Abstract][Full Text] [Related]
11. TDP-43 loss of function inhibits endosomal trafficking and alters trophic signaling in neurons.
Schwenk BM; Hartmann H; Serdaroglu A; Schludi MH; Hornburg D; Meissner F; Orozco D; Colombo A; Tahirovic S; Michaelsen M; Schreiber F; Haupt S; Peitz M; Brüstle O; Küpper C; Klopstock T; Otto M; Ludolph AC; Arzberger T; Kuhn PH; Edbauer D
EMBO J; 2016 Nov; 35(21):2350-2370. PubMed ID: 27621269
[TBL] [Abstract][Full Text] [Related]
12. Activation of Phosphotyrosine-Mediated Signaling Pathways in the Cortex and Spinal Cord of SOD1
Mallozzi C; Spalloni A; Longone P; Domenici MR
Neural Plast; 2018; 2018():2430193. PubMed ID: 30154836
[TBL] [Abstract][Full Text] [Related]
13. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
14. Progressive impairment of CaV1.1 function in the skeletal muscle of mice expressing a mutant type 1 Cu/Zn superoxide dismutase (G93A) linked to amyotrophic lateral sclerosis.
Beqollari D; Romberg CF; Dobrowolny G; Martini M; Voss AA; Musarò A; Bannister RA
Skelet Muscle; 2016; 6():24. PubMed ID: 27340545
[TBL] [Abstract][Full Text] [Related]
15. The Overexpression of TDP-43 Protein in the Neuron and Oligodendrocyte Cells Causes the Progressive Motor Neuron Degeneration in the SOD1 G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
Lu Y; Tang C; Zhu L; Li J; Liang H; Zhang J; Xu R
Int J Biol Sci; 2016; 12(9):1140-9. PubMed ID: 27570488
[TBL] [Abstract][Full Text] [Related]
16. Targeting Extracellular Cyclophilin A Reduces Neuroinflammation and Extends Survival in a Mouse Model of Amyotrophic Lateral Sclerosis.
Pasetto L; Pozzi S; Castelnovo M; Basso M; Estevez AG; Fumagalli S; De Simoni MG; Castellaneta V; Bigini P; Restelli E; Chiesa R; Trojsi F; Monsurrò MR; Callea L; Malešević M; Fischer G; Freschi M; Tortarolo M; Bendotti C; Bonetto V
J Neurosci; 2017 Feb; 37(6):1413-1427. PubMed ID: 28011744
[TBL] [Abstract][Full Text] [Related]
17. Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations.
Jeon GS; Shim YM; Lee DY; Kim JS; Kang M; Ahn SH; Shin JY; Geum D; Hong YH; Sung JJ
Mol Neurobiol; 2019 Mar; 56(3):2007-2021. PubMed ID: 29982983
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model.
Li QX; Mok SS; Laughton KM; McLean CA; Volitakis I; Cherny RA; Cheung NS; White AR; Masters CL
Aging Cell; 2006 Apr; 5(2):153-65. PubMed ID: 16626394
[TBL] [Abstract][Full Text] [Related]
19. Astrocyte-derived Jagged-1 mitigates deleterious Notch signaling in amyotrophic lateral sclerosis.
Nonneman A; Criem N; Lewandowski SA; Nuyts R; Thal DR; Pfrieger FW; Ravits J; Van Damme P; Zwijsen A; Van Den Bosch L; Robberecht W
Neurobiol Dis; 2018 Nov; 119():26-40. PubMed ID: 30010003
[TBL] [Abstract][Full Text] [Related]
20. Regulation of system x(c)- in the SOD1-G93A mouse model of ALS.
Albano R; Liu X; Lobner D
Exp Neurol; 2013 Dec; 250():69-73. PubMed ID: 24041987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]